Anagenex, which combines AI and large-scale proprietary datasets for drug discovery, has raised a $30M Series A led by Catalio Capital Management — The CEO of Anagenex believes that the company’s AI engine trained on billions of data points and iterative testing will blow other AI drug discovery startups out of the water.
Hey there! Can chewing gum help you achieve that chiseled jawline you've been dreaming of?…
Hey there, fellow games enthusiasts! Have you ever wondered just how your favorite gaming platform,…
When it comes to durable, stylish, and cost-effective flooring solutions, epoxy flooring stands out as…
Hi there, fellow gaming enthusiasts! Regardless of whether you're a seasoned player or perhaps dipping…
Hey there, furniture lovers of Fort Worth! Whether you're setting up a new home or…
You have probably heard about the importance of socializing a dog after getting a puppy.…